Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Gan & Lee Pharmaceuticals.
  6. News
  7. Summary
    603087   CNE100003ZH1

GAN & LEE PHARMACEUTICALS.

(603087)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Gan & Lee Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020

10/27/2020 | 05:25am EST

Gan & Lee Pharmaceuticals Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 2,191.734 million compared to CNY 1,853.290 million a year ago. Operating income was CNY 841.720 million compared to CNY 818.862 million a year ago. Net income was CNY 686.204 million compared to CNY 661.484 million a year ago. Basic earnings per share from continuing operations was CNY 1.28 compared to CNY 1.31 a year ago.


ę S&P Capital IQ 2020
All news about GAN & LEE PHARMACEUTICALS.
10/27Gan & Lee Pharmaceuticals. Reports Earnings Results for the Nine Months Ended September..
CI
10/14GAN & LEE PHARMACEUTICALS : Concludes Phase 3 Studies of Gan & Lee Insulin Glargine (GL-GL..
AQ
08/26Gan & Lee Pharmaceuticals. Reports Earnings Results for the Half Year Ended June 30, 20..
CI
07/02GAN & LEE PHARMACEUTICALS : New Data on Phase 1 Proposed Biosimilar Gan & Lee Insulins Asp..
AQ
07/02Gan & Lee Pharmaceuticals Co., Ltd. Announces Positive Phase 1 Clinical Trial Results a..
CI
04/29Gan & Lee Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ende..
CI
04/14Gan & Lee Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended De..
CI
04/06GAN & LEE PHARMACEUTICALS : & Lee Pharma's Tumor Drug Wins Orphan Drug Designation in Euro..
MT
03/21GAN & LEE PHARMACEUTICALS CO., LTD.( : 603087) added to FTSE All-World Index
CI
01/29FDA Grants Fast Track Designation for Gan & Lee Pharmaceuticals Co., Ltd.'s GLR2007, fo..
CI
More news
Financials
Sales 2021 3 786 M 592 M 592 M
Net income 2021 1 436 M 225 M 225 M
Net Debt 2021 - - -
P/E ratio 2021 29,5x
Yield 2021 -
Capitalization 42 402 M 6 634 M 6 633 M
Capi. / Sales 2021 11,2x
Capi. / Sales 2022 10,2x
Nbr of Employees 2 934
Free-Float 17,2%
Chart GAN & LEE PHARMACEUTICALS.
Duration : Period :
Gan & Lee Pharmaceuticals. Technical Analysis Chart | 603087 | CNE100003ZH1 | MarketScreener
Technical analysis trends GAN & LEE PHARMACEUTICALS.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 75,51 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Zhong Ru Gan Chairman
Yan Sun Independent Director
Yan Qing He Independent Director
Guo Jun Zheng Independent Director
Kai Du Director & Director-International Department
Sector and Competitors
1st jan.Capi. (M$)
GAN & LEE PHARMACEUTICALS.-42.89%6 634
CSL LIMITED10.18%101 196
WUXI BIOLOGICS (CAYMAN) INC.0.58%56 285
SAMSUNG BIOLOGICS CO.,LTD.5.33%48 100
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.-0.80%35 680